Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Post by Blueseaon Dec 28, 2022 11:11pm
392 Views
Post# 35194711

Sharing Globe and Mail Article..SQI Diagnostics

Sharing Globe and Mail Article..SQI Diagnostics

SQI Diagnostics: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (SQD)

The Globe and Mail - Mon Dec 26, 10:02AM CST
 

SQI Diagnostics is now ranked among the top 10 undervalued stocks in the Medical Diagnostics & Research industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below).

 

Medical Diagnostics & Research: Companies that provide laboratory testing services through imaging and other diagnostic services to the medical industry. Stocks in this category are held primarily for capital appreciation.

 

More about SQI Diagnostics

All data provided as-at market close December 22, 2022. The list is sorted by stocks with the greatest percentage difference between valuation and price. SQI Diagnostics SQI Diagnostics Inc is a Canada based diagnostics company. It is engaged in developing and commercializing proprietary technologies and products for multiplexing diagnostics. SQI Diagnostics is listed under SQD on the TSX Venture Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs. StockCalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. StockCalc's Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including: Discounted Cash Flow (DCF), Price & Other Comparables, Multiples, Adjusted Book Value (ABV) and Analyst Consensus

 

https://www.theglobeandmail.com/investing/markets/stocks/SQD-X/pressreleases/12803463/sqi-diagnostics-top-10-undervalued-medical-diagnostics-research-industry-stocks-sqd/

Looking forward to hearing the updates during the quarterly earnings report at the end of January.

 

 

<< Previous
Bullboard Posts
Next >>